ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,245Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 19

$458K Total Retail Price of All Prescriptions

Rank: 8 out of 19

491 Patients Receiving at Least One Drug in Part D
98%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 491 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

4% of this provider’s 491 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 8,962 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 39.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
LISINOPRIL 506 488 1 6
AMLODIPINE BESYLATE 444 441 2 3
SIMVASTATIN 303 291 3 7
DONEPEZIL HCL 256 255 4 9
PRAVASTATIN SODIUM 244 244 5 32
METOPROLOL TARTRATE 235 234 6 13
LEVOTHYROXINE SODIUM 229 227 7 4
CITALOPRAM HBR 223 221 8 15
MIRTAZAPINE 205 205 9 14
RANITIDINE HCL 169 159 10 17
HYDROCHLOROTHIAZIDE 168 166 11 28
FUROSEMIDE 160 149 12 2
SERTRALINE HCL 159 159 13 25
ATORVASTATIN CALCIUM 147 143 14 38
NAMENDA 143 142 15 8
OMEPRAZOLE 141 138 16 5
ATENOLOL 136 123 17 36
QUETIAPINE FUMARATE 128 122 18 22
GABAPENTIN 123 116 19 12
POTASSIUM CHLORIDE 120 115 20 11
DIOVAN 118 118 21 41
ALENDRONATE SODIUM 115 115 22 50
METOPROLOL SUCCINATE 106 104 23 33
TRAMADOL HCL 102 91 24 16
ZOLPIDEM TARTRATE 98 98 25 34
FLUTICASONE PROPIONATE 89 76 26 45
METFORMIN HCL 86 77 27 26
TRAZODONE HCL 85 79 28 20
ISOSORBIDE MONONITRATE ER 83 83 29 42
CLOPIDOGREL 83 83 29 30
CARVEDILOL 77 77 31 23
FAMOTIDINE 74 74 32 31
KLOR-CON M20 69 69 33 59
LIDODERM 66 66 34 76
PLAVIX 65 65 35 39
RISPERIDONE 64 64 36 18
LOSARTAN POTASSIUM 64 64 36 43
HYDROCODONE-ACETAMINOPHEN 64 55 S3 36 1
SEROQUEL 62 61 39 48
LEVETIRACETAM 61 45 40 57
NIFEDIPINE ER 56 56 41 126
ESCITALOPRAM OXALATE 54 54 42 21
WARFARIN SODIUM 52 52 43 10
SYNTHROID 51 51 44 253
HYDRALAZINE HCL 50 50 45 58
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 5, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.